Did you know that prostate cancer is the second most prevalent cancer in American men, following skin cancer? A new diagnosis of prostate cancer occurs every two minutes.
We are delighted to partner with Oxford Biodynamics for today’s episode with Dr. Robert Heaton, who joins us to discuss a ground-breaking new prostate cancer screening test that predicts the risk of prostate cancer with 94% accuracy, using a simple blood test.
Dr. Heaton is a board-certified pathologist. He completed his medical training at Georgetown University and then spent the next twenty years in the US Navy. After finishing his residency training in pathology, Dr. Heaton became the Director of Laboratory and Clinical Support Services for the National Naval Medical Center before joining various hospital pathology labs and life sciences companies. He is currently the Laboratory Medical Director for Oxford Biodynamics at their CLIA-certified clinical lab in Maryland, where he oversees the clinical operations of their liquid biopsy blood tests.
In today’s episode, we dive into the details of the innovative EpiSwitch Prostate Screening test, known as the PSE, designed to confirm the presence of prostate cancer, whether symptoms are present or not. This technological advancement is a game-changer! It empowers urologists by providing a precise tool to assess whether a patient should undergo a biopsy or opt for continued monitoring.
Stay tuned to learn how this simple yet powerful tool streamlines the screening process for men struggling with prostate cancer.
Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.
Show Highlights:
- At what age should men start getting checked for prostate cancer?
- What the screening for prostate cancer typically entails
- The importance of establishing a baseline to monitor how PSA changes over time
- Dr. Heaton dives into the details of the EpiSwitch PSE test
- How men can access the EpiSwitch PSE test
- Dr. Heaton discusses the accuracy of the EpiSwitch PSE test
- What is the expected turnaround time for the EpiSwitch PSE test results?
- Dr. Heaton explains the role of the EpiSwitch PSE test in different scenarios
The revolutionary EpiSwitch Prostate Screening test has remarkable accuracy in predicting prostate cancer risk through a simple blood test. It holds immense promise for men battling prostate cancer by providing urologists with a precise diagnostic tool and offering a streamlined approach for patients facing the complexities of prostate cancer.
Links:
Follow Dr. Pohlman on Twitter and Instagram – @gpohlmanmd
Get your free What To Expect Guide (or find the link on our podcast website)
Join our Facebook group
Follow Dr. Pohlman on Twitter and Instagram
Go to the Prostate Health Academy to sign up.
You can access Dr. Pohlman’s free mini webinar, where he discusses his top three tips to promote men’s prostate health, longevity, and quality of life here.
Oxford BioDynamics:
Twitter: @oxbiodynamics and #OBD
Instagram: @oxbiodynamics
YouTube: @oxfordbiodynamics
PSE:
Twitter: (@94percent_com)
Instagram: (@get_the_pse)
Recent Comments